iShares Biotechnology ETF (NASDAQ:IBB) Shares Purchased by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 32.9% in the 3rd quarter, HoldingsChannel reports. The firm owned 663,000 shares of the financial services provider’s stock after purchasing an additional 164,000 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in iShares Biotechnology ETF were worth $96,533,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Williams Financial LLC acquired a new position in iShares Biotechnology ETF in the 2nd quarter valued at about $867,000. PVG Asset Management Corp acquired a new position in iShares Biotechnology ETF in the 2nd quarter valued at about $415,000. Huntington National Bank increased its stake in shares of iShares Biotechnology ETF by 17.9% during the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after acquiring an additional 160 shares during the last quarter. Concourse Financial Group Securities Inc. increased its stake in shares of iShares Biotechnology ETF by 22.4% during the 2nd quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock valued at $90,000 after acquiring an additional 120 shares during the last quarter. Finally, Raymond James & Associates increased its stake in shares of iShares Biotechnology ETF by 4.4% during the 2nd quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after acquiring an additional 7,931 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.2 %

NASDAQ IBB opened at $140.23 on Wednesday. iShares Biotechnology ETF has a 12 month low of $117.28 and a 12 month high of $150.57. The company has a 50-day moving average of $143.27 and a 200-day moving average of $141.92.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.